NeutraKine FLT3 Ligand Monoklonaler Antikörper
NeutraKine FLT3 Ligand Monoklonal Antikörper für Neutralization, ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human
Anwendung
Neutralization, ELISA
Konjugation
Unkonjugiert
CloneNo.
3E1A3
Kat-Nr. : 69032-1-Ig
Synonyme
Galerie der Validierungsdaten
Neutralization | OCI-AML5 |
Produktinformation
69032-1-Ig bindet in Neutralization, ELISA NeutraKine FLT3 Ligand und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Maus / IgG1 |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | human NeutraKine FLT3 Ligand protein HZ-1151 |
Vollständiger Name | fms-related tyrosine kinase 3 ligand |
Gene symbol | FLT3LG |
Gene ID (NCBI) | 2323 |
Konjugation | Unkonjugiert |
Form | Lyophilized Powder |
Reinigungsmethode | Protein-G-Reinigung |
Lagerungspuffer | Sterile PBS. |
Endotoxin | <0.1 EU/μg |
Wiederherstellung | This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use. |
Stability and Storage | Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products. |
Hintergrundinformationen
The FMS-related tyrosine kinase 3 (FLT3) ligand (FLT3LG), a growth factor, is mainly derived from lymphocytes in the tumor microenvironment. It binds to FLT3 on DCs to enhance their differentiation and expansion. Therefore, it may assist DCs in tumor antigen presentation and antitumor immune response. In addition, mature DCs express FLT3 and proliferate massively under the trigger of FLT3LG.
This antibody is used to neutralize the bioactivity of FLT3 Ligand.